Processing of plasmid DNA with ColE1-like replication origin

Plasmid

Volumn 51, Issue 3, 2004, Pages 149-161

  Wang, Zhijun ^a   Yuan, Zhenghong ^a   Hengge, Ulrich R ^b  

^a FUDAN UNIVERSITY   (China)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

ColE1; DNA vaccine; Escherichia coli; Fermentation; Gene therapy; Plasmid DNA; Purification

Indexed keywords

AMINO ACID; DNA DIRECTED DNA POLYMERASE BETA; DNA VACCINE; GUANINE NUCLEOTIDE BINDING PROTEIN; NUCLEOSIDE; PLASMID DNA; RIBONUCLEASE H; RIBONUCLEASE III; RNA DERIVATIVE; TRANSFER RNA;

ADSORPTION CHROMATOGRAPHY; CYTOLYSIS; DNA PURIFICATION; DNA REPLICATION ORIGIN; DNA SYNTHESIS; FERMENTATION; GENE FUNCTION; GENE THERAPY; GENETIC RECOMBINATION; HEAT TREATMENT; MICROFILTRATION; MOLECULAR INTERACTION; QUALITY CONTROL; REVIEW; RNA BINDING; RNA HYBRIDIZATION; RNA INTERFERENCE;

BACTERIAL PROTEINS; DNA REPLICATION; GENETIC ENGINEERING; MODELS, GENETIC; PLASMIDS; REPLICATION ORIGIN; RNA, TRANSFER;

ESCHERICHIA COLI;

EID: 1942519233     PISSN: 0147619X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.plasmid.2003.12.002     Document Type: Review

References (106)

1. Barnett R.N., Cleveland C.L., Joy A., Landman U., Schuster G.B. Charge migration in DNA: ion-gated transport. Science. 294:2001;567-571.
2. Binnie U., Wong K., McAteer S., Masters M. Absence of RNase III alters the pathway by which RNA I, the antisense inhibitor of ColE1 replication, decays. Microbiology. 145:1999;3089-3100.
3. Birnboim H.C., Doly J. A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res. 7:1979;1513-1523.
4. Biswas S.B., Biswas E.E. Regulation of dnaB function in DNA replication in Escherichia coli by dnaC and. λP gene products J. Biol. Chem. 262:1987;7831-7838.
5. Carlson A., Signs M., Liermann L., Boor R., Jem K.J. Mechanical disruption of Escherichia coli for plasmid recovery. Biotechnol. Bioeng. 48:1995;303-315.
6. Cesareni G., Helmer-Citterich M., Castagnoli L. Control of ColE1 plasmid replication by antisense RNA. Trends Genet. 7:1991;230-235.
7. Chamsart S., Patel H., Hanak J.A., Hitchcock A.G., Nienow A.W. The impact of fluid-dynamic-generated stresses on chDNA and pDNA stability during alkaline cell lysis for gene therapy products. Biotechnol. Bioeng. 75:2001;387-392.
8. Chan P.T., Ohmori H., Tomizawa J., Lebowitz J. Nucleotide sequence and gene organization of ColE1 DNA. J. Biol. Chem. 260:1985;8925-8935.
9. Chen W., Graham C., Ciccarelli R.B. Automated fed-batch fermentation with feed-back controls based on dissolved oxygen (DO) and pH for production of DNA vaccines. J. Ind. Microbiol. Biotechnol. 18:1997;43-48.
10. Ciccolini L.A., Shamlou P.A., Titchener-Hooker N. A mass balance study to assess the extent of contaminant removal achieved in the operations for the primary recovery of plasmid DNA from Escherichia coli cells. Biotechnol. Bioeng. 77:2002;796-805.
11. Clemson M., Kelly W.J. Optimizing alkaline lysis for DNA plasmid recovery. Biotechnol. Appl. Biochem. 37:2003;235-244.
12. Clewell D.B. Nature of ColE1 plasmid replication in the presence of chloramphenicol. J. Bacteriol. 110:1972;667-676.
13. Dandanell G., Norris K., Hammer K. Long-distance deoR regulation of gene expression in Escherichia coli. Ann. N. Y. Acad. Sci. 646:1991;19-30.
14. Dasgupta S., Masukata H., Tomizawa J. Multiple mechanisms for initiation of ColE1 DNA replication: DNA synthesis in the presence and absence of ribonuclease H. Cell. 51:1987;1113-1122.
15. Diogo M.M., Queiroz J.A., Monteiro G.A., Martins S.A., Ferreira G.N., Prazeres D.M. Purification of a cystic fibrosis plasmid vector for gene therapy using hydrophobic interaction chromatography. Biotechnol. Bioeng. 68:2000;576-583.
16. Donoghue D.J., Sharp P.A. Replication of colicine E1 plasmid DNA in vivo requires no plasmid-encoded proteins. J. Bacteriol. 133:1978;1287-1294.
17. Donovan W.P., Kushner S.R. Polynucleotide phosphorylase and ribonuclease II are required for cell viability and mRNA turnover in Escherichia coli K-12. Proc. Natl. Acad. Sci. USA. 83:1986;120-124.
18. Dooley T.P., Polisky B. Suppression of ColE1 RNA-RNA mismatch mutations in vivo by the ColE1 Rop protein. Plasmid. 18:1987;24-34.
19. Eastman E.M., Durland R.H. Manufacturing and quality control of plasmid-based gene expression systems. Adv. Drug Deliv. Rev. 30:1998;33-48.
20. Ederth J., Isaksson L.A., Abdulkarim F. Origin-specific reduction of ColE1 plasmid copy number due to mutations in a distinct region of the Escherichia coli RNA polymerase. Mol. Genet. Genomics. 267:2002;587-592.
21. Endres H.N., Johnson J.A., Ross C.A., Welp J.K., Etzel M.R. Evaluation of an ion-exchange membrane for the purification of plasmid DNA. Biotechnol. Appl. Biochem. 37:2003;259-266.
22. Eon-Duval A., MacDuff R.H., Fisher C.A., Harris M.J., Brook C. Removal of RNA impurities by tangential flow filtration in an RNase-free plasmid DNA purification process. Anal. Biochem. 316:2003;66-73.
23. Ferreira G.N., Monteiro G.A., Prazeres D.M., Cabral J.M. Downstream processing of plasmid DNA for gene therapy and DNA vaccine applications. Trends Biotechnol. 18:2000;380-388.
24. Frost L.S., Ippen-Ihler K., Skurray R.A. Analysis of the sequence and gene products of the transfer region of the F sex factor. Microbiol. Rev. 58:1994;162-210.
25. Fukuoh A., Iwasaki H., Ishioka K., Shinagawa H. ATP-dependent resolution of R-loops at the ColE1 replication origin by Escherichia coli RecG protein, a Holliday junction-specific helicase. EMBO J. 16:1997;203-209.
26. Gluck L., Alazay L., Ratel D., Puget S., Wion D. Quality control of plasmid preparations. Nat. Biotechnol. 19:2001;715.
27. Grabherr R., Bayer K. Impact of targeted vector design on ColE1 plasmid replication. Trends Biotechnol. 20:2002;257-260.
28. Grabherr R., Nilsson E., Striedner G., Bayer K. Stabilizing plasmid copy number to improve recombinant protein production. Biotechnol. Bioeng. 77:2002;142-147.
29. Hecker M., Schroeter A., Mack F. Replication of pBR322 DNA in stringent and relaxed strains of Escherichia coli. Mol. Gen. Genet. 190:1983;355-357.
30. Hecker M., Schroeter A., Mach F. Escherichia coli rela strains as hosts for amplification of pBR322 plasmid DNA. FEMS Microbiol. Lett. 29:1985;331-334.
31. Hecker M., Schroeter A., Mach F. Physiological studies on pBR322 DNA amplification in an Escherichia coli relA strain. J. Basic Microbiol. 26:1986;329-333.
32. Hecker M., Schroeter A., Trader K., Mach F. Role of relA mutation in the survival of amino acid-starved Escherichia coli. Arch. Microbiol. 143:1986;400-402.
33. Hofman C.R., Dileo J.P., Li Z., Li S., Huang L. Efficient in vivo gene transfer by PCR amplified fragment with reduced inflammatory activity. Gene Ther. 8:2001;71-74.
34. Hofmann K.H., Neubauer P., Reithdorf S., Hecker M. Amplification of pBR322 plasmid DNA in Escherichia coli relA strains during batch and fed-batch fermentation. J. Basic Microbiol. 30:1990;37-41.
35. Holmes D.S., Ouigley M. A rapid boiling method for the preparation of bacteria plasmids. Anal. Biochem. 114:1981;193-197.
36. Horn N.A., Meek J.A., Budahazi G., Marquet M. Cancer gene therapy using plasmid DNA: purification of DNA for human clinical trials. Hum. Gene Ther. 6:1995;565-573.
37. ′ tail shortening by Escherichia coli ribonuclease E Nature. 391:1998;99-102.
38. Ito T., Smith C.L., Cantor C.R. Sequence-specific DNA purification by triplex affinity capture. Proc. Natl. Acad. Sci. USA. 89:1992;495-498.
39. Itoh T., Tomizawa J. Initiation of replication of plasmid ColE1 DNA by RNA polymerase, ribonuclease H and DNA polymerase I. Cold Sping Harbor Symp. Quant. Biol. 43:1978;409-417.
40. Itoh T., Tomizawa J. Formation of an RNA primer for initiation of replication of ColE1 DNA by ribonuclease H. Proc. Natl. Acad. Sci. USA. 77:1980;2450-2454.
41. Jekel M., Wackernagel W. Location of the endA gene coding for endonuclease I on the physical map of the Escherichia coli K-12 chromosome. J. Bacteriol. 176:1994;1550-1551.
42. Jung Y.H., Lee Y. RNases in ColE1 DNA metabolism. Mol. Biol. Rep. 22:1995;195-200.
43. Jung Y.H., Park I., Lee Y. Alteration of RNA I metabolism in a temperature-sensitive Escherichia coli rnpA mutant strain. Biochem. Biophys. Res. Commun. 186:1992;1463-1470.
44. Kahn D.W., Butler M.D., Cohen D.L., Gordon M., Kahn J.W., Winkler M.E. Purification of plasmid DNA by tangential flow filtration. Biotechnol. Bioeng. 69:2000;101-106.
45. Kedzierska B., Glinkowska M., Iwanicki A., Obuchowski M., Sojka P., Thomas M.S., Wegrzyn G. Toxicity of the bacteriophage lambda cII gene product to Escherichia coli arises from inhibition of host cell DNA replication. Virology. 313:2003;622-628.
46. Kelly W.J. Perspectives on plasmid-based gene therapy: challenges for the product and the process. Biotechnol. Appl. Biochem. 37:2003;219-223.
47. Kendall D., Lye G.J., Levy M.S. Purification of plasmid DNA by an integrated operation comprising tangential flow filtration and nitrocellulose adsorption. Biotechnol. Bioeng. 79:2002;816-822.
48. Kopp M.U., de Mello A.J., Manz A. Chemical amplification: continuous-flow PCR on a chip. Science. 280:1998;1046-1048.
49. Kues U., Stahl U. Replication of plasmid in gram-negative bacteria. Microbiol. Rev. 53:1989;491-516.
50. Lacatena R.M., Banner D.W., Castagnoli L., Cesareni G. Control of initiation of pMB1 replication: purified Rop protein and RNA I affect primer formation in vitro. Cell. 37:1984;1009-1014.
51. Lahijani R., Hulley G., Soriano G., Horn N.A., Marquet M. High-yield production of pBR322-derived plasmids intended for human gene therapy by employing a temperature-controllable point mutation. Hum. Gene Ther. 7:1996;1971-1980.
52. LeBowitz J.H., McMacken R. The Escherichia coli dnaB replication protein is a DNA helicase. J. Biol. Chem. 261:1986;4738-4748.
53. ′ protein Proc. Natl. Acad. Sci. USA. 88:1991;3029-3032.
54. Lemmens R., Olsson U., Nyhammar T., Stadler J. Supercoiled plasmid DNA: selective purification by thiophilic/aromatic adsorption. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 784:2003;291-300.
55. Levy M.S., Collins I.J., Tsai J.T., Shamlou P.A., Ward J.M., Dunnill P. Removal of contaminant nucleic acids by nitrocellulose filtration during pharmaceutical-grade plasmid DNA processing. J. Biotechnol. 76:2000;197-205.
56. Levy M.S., O'Kennedy R.D., Ayazi-Shamlou P., Dunnill P. Biochemical engineering approaches to the challenges of producing pure plasmid DNA. Trends Biotechnol. 18:2000;296-305.
57. Li S., Ma Z. Nonviral gene therapy. Curr. Gene Ther. 1:2001;201-226.
58. Lin-Chao S., Bremer H. Activities of the RNA I and RNA II promoters of plasmid pBR322. J. Bacteriol. 169:1987;1217-1222.
59. Lin-Chao S., Chen W.T., Wong T.T. High copy number of the pUC plasmid results from a Rom/Rop-suppressible point mutation in RNA II. Mol. Microbiol. 22:1992;3385-3393.
60. Lin-Chao S., Wong T.T., McDowall K.J., Cohen S.N. Effects of nucleotide sequence on the specificity of rne-dependent and RNase E-mediated cleavages of RNA I encoded by the pBR322 plasmid. J. Biol. Chem. 269:1994;10797-10803.
61. Lopilato J., Bortner S., Beckwith J. Mutations in a new chromosomal gene of Escherichia coli K-12, pcnB, reduce plasmid copy number of pBR322 and its derivatives. Mol. Gen. Genet. 205:1986;285-290.
62. Luisi-DeLuca C., Lovett S.T., Kolodner R.D. Genetic and physical analysis of plasmid recombination in recB recC sbcB and recB recC sbcA Escherichia coli K-12 mutants. Genetics. 122:1989;269-278.
63. ′ sites on the replication of plasmid ColE1 J. Biol. Chem. 263:1988;15008-15015.
64. Marvin H.J.P., ter beest M.B.A., Witholt B. Release of outer membrane fragments from wild type Escherichia coli and from several E. coli lipopolysaccharide mutants by EDTA and heat shock treatments. J. Bacteriol. 171:1989;5262-5267.
65. Masai H., Asai T., Kubota Y., Arai K., Kogoma T. Escherichia coli PriA protein is essential for inducible and constitutive stable DNA replication. EMBO J. 13:1994;5338-5345.
66. Masukata H., Tomizawa J. Effects of point mutations on formation and structure of the RNA primer for ColE1 replication. Cell. 36:1984;513-522.
67. Masukata H., Tomizawa J. Control of primer formation for ColE1 plasmid replication: conformational change of the primer transcript. Cell. 44:1986;125-136.
68. Masukata H., Dasgupta S., Tomizawa J. Transcriptional activation of ColE1 DNA synthesis by displacement of the nontranscribed strand. Cell. 51:1987;1123-1130.
69. Ohmori H., Murakami Y., Nagata T. Nucleotide sequences required for a ColE1-type plasmid to replicate in Escherichia coli cells with or without RNase H. J. Mol. Biol. 198:1987;223-234.
70. O'kennedy R.D., Ward J.M., Keshavarz-Moore E. Effects of fermentation strategy on the characteristics of plasmid DNA production. Biotechnol. Appl. Biochem. 37:2003;83-90.
71. Prazeres D.M., Ferreira G.N., Monteiro G.A., Cooney C.L., Cabral J.M. Large-scale production of pharmaceutical-grade plasmid DNA for gene therapy: problems and bottlenecks. Trends Biotechnol. 17:1999;169-174.
72. Prazeres D.M., Monteiro G.A., Ferreira G.N., Diogo M.M., Ribeiro S.C., Cabral J.M. Purification of plasmids for gene therapy and DNA vaccination. Biotechnol. Annu. Rev. 7:2001;1-30.
73. Prazeres D.M., Schluep T., Cooney C. Preparative purification of supercoiled plasmid DNA using anion-exchange chromatography. J. Chromatogr. A. 806:1998;31-45.
74. Reiser J. Production and concentration of pseudotyped HIV-1-based gene transfer vectors. Gene Ther. 7:2000;910-913.
75. Robertson J., Griffiths E. WHO guidelines for assuring the quality of DNA vaccines. Biologicals. 26:1998;205-212.
76. Sarkar N., Cao G.J., Jain C. Identification of multicopy suppressors of the pcnB plasmid copy number defect in Escherichia coli. Mol. Genet. Genomics. 268:2002;62-69.
77. Schorr J., Moritz P., Seddon T., Schleef M. Plasmid DNA for human gene therapy and DNA vaccines. Production and quality assurance. Ann. N. Y. Acad. Sci. 772:1995;271-273.
78. Seelke R., Kline B.C., Aleef R., Porter R.D., Shields M.S. Mutations in the recD gene of Escherichia coli that raise the copy number of certain plasmids. J. Bacteriol. 169:1987;4841-4844.
79. Selzer G., Tomizawa J. Speicific cleavage of the p15A primer precursor by ribonuclease H at the origin of DNA replication. Proc. Natl. Acad. Sci. USA. 79:1982;7082-7086.
80. Seufert W., Messer W. DnaA protein binding to the plasmid origin region can substitute for primosome assembly during replication of pBR322 in vitro. Cell. 48:1987;73-78.
81. Shamlou P.A. Scalable processes for the manufacture of therapeutic quantities of plasmid DNA. Biotechnol. Appl. Biochem. 37:2003;207-218.
82. Sharma A.K., Khuller G.K. DNA vaccines: future strategies and relevance to intracellular pathogens. Immunol. Cell Biol. 79:2001;537-546.
83. Smith K.T., Shepard A.J., Boyd J.E., Lees G.M. Gene delivery systems for use in gene therapy: an overview of quality assurance and safety issues. Gene Ther. 3:1996;190-200.
84. Thomas C.M. Recent studies on the control of plasmid replication. Biochim. Biophys. Acta. 949:1988;253-263.
85. Thomas N.R., Koshy S., Simsek M., Abraham A.K. A precaution when preparing very large plasmids by alkaline lysis procedure. Biotechnol. Appl. Biochem. 10:1988;402-407.
86. Tomizawa J. Control of ColE1 plasmid replication: the process of binding of RNA I to the primer transcript. Cell. 38:1984;861-870.
87. Tomizawa J. Control of ColE1 plasmid replication: initial interaction of RNA I and the primer transcript is reversible. Cell. 40:1985;527-535.
88. Ulanowska K., Sikora A., Wegrzyn G., Czyz A. Role of the cgtA gene function in DNA replication of extrachromosomal elements in Escherichia coli. Plasmid. 50:2003;45-52.
89. van Reis R., Zydney A. Membrane separations in biotechnology. Curr. Opin. Biotechnol. 12:2001;208-211.
90. Varley D.L., Hitchcock A.G., Weiss A.M., Horler W.A., Cowell R., Peddie L., Sharpe G.S., Thatcher D.R., Hanak J.A. Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography. Bioseparation. 8:1999;209-217.
91. Vincent S.D., Mahdi A.A., Lloyd R.G. The RecG branch migration protein of Escherichia coli dissociates R-loops. J. Mol. Biol. 264:1996;713-721.
92. Wang Z., Le G., Shi Y., Wegrzyn G. Medium design for plasmid DNA production based on stoichiometric model. Process Biochem. 36:2001;1085-1093.
93. Wang Z., Le G., Shi Y., Wegrzyn G. Studies on recovery plasmid DNA from Escherichia coli by heat treatment. Process Biochem. 38:2002;199-206.
94. Wang Z., Le G., Shi Y., Wegrzyn G. Purification of plasmid DNA using multicompartment electrolyzer secluded by ultrafilter membranes. Biotechnol. Lett. 24:2002;121-124.
95. Wang Z., Le G., Shi Y., Wegrzyn G., Wróbel B. A model for regulation of ColE1-like plasmid replication by uncharged tRNAs in amino acid-starved Escherichia coli cells. Plasmid. 47:2002;69-78.
96. Wegrzyn G. Replication of plasmids during bacterial response to amino acid starvation. Plasmid. 41:1999;1-16.
97. Wittmann C. Metabolic flux analysis using mass spectrometry. Adv. Biochem. Eng. Biotechnol. 74:2002;39-64.
98. Wong E.M., Polisky B. Alternative conformations of the ColE1 replication primer modulate its interaction with RNA I. Cell. 42:1985;959-966.
99. Wróbel B., Wegrzyn G. Differential amplification efficiency of pMB1 and p15A (ColE1-type) replicons in Escherichia coli stringent and relaxed strains starved for particular amino acids. Microbiol. Res. 152:1997;251-255.
100. Wróbel B., Wegrzyn G. Replication regulation of ColE1-like plasmids in amino acid-starved Escherichia coli. Plasmid. 39:1998;48-62.
101. ′ phosphorylation Nature. 374:1995;180-183.
102. Xu F.F., Gaggero C., Cohen S.N. Polyadenylation can regulate ColE1 type plasmid copy number independently of any effect on RNA I decay by decreasing the interaction of antisense RNA I with its RNA II target. Plasmid. 48:2002;49-58.
103. Xu F., Lin-Chao S., Cohen S.N. The Escherichia coli pcnB gene promotes adenylylation of antisense RNA I of ColE1-type plasmids in vivo and degradation of RNA I decay intermediates. Proc. Natl. Acad. Sci. USA. 90:1993;6756-6760.
104. Yavachev L., Ivanov I. What does the homology between E. coli tRNAs and RNAs controlling ColE1 plasmid replication mean? J. Theor. Biol. 131:1988;235-241.
105. Yokota T., Sakamoto N., Enomoto N., Tanabe Y., Miyagishi M., Maekawa S., Yi L., Kurosaki M., Taira K., Watanabe M., Mizusawa H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4:2003;602-608.
106. Zhang S., Krivosheyeva A., Nochumson S. Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules. Biotechnol. Appl. Biochem. 37:2003;245-249.